Design: To evaluate the efficacy of the main tools in the diagnostic localization of hyperfunctioning parathyroids (HP) in primary hyperparathyroidism (pHPT) with concomitant thyroid diseases. Methods: Forty-three patients with pHPT associated with nodular goiter (NG, nZ32) and/or autoimmune thyroid diseases (AITDs, nZ11) for a total of 63 neck lesions were considered. Sixteen patients displaying HP (16 lesions), unequivocally localized by sestaMIBI scintigraphy (MIBI) and neck ultrasound (US) (group I), were compared with 27 patients (47 neck lesions) displaying equivocal parathyroid localization (group II). In all cases, neck US, MIBI scan, cytology, and parathyroid hormone assay in fine-needle aspiration washout fluid (FNA-PTH) were performed. All patients finally underwent surgery. Results: According to histological examination, high FNA-PTH values (O103 pg/ml) correctly identified all HP in both groups of patients (100% of sensitivity and specificity). Both MIBI and US correctly identified all HP only in group I patients; in contrast, four patterns of mismatch between these techniques were observed in group II patients, leading to low diagnostic performances of neck US (71.4% sensitivity and 78.9% specificity) and of MIBI scan (35.7% sensitivity and 42.1% specificity). The latter was due to both false-negative (mainly in AITD) and false-positive (mainly in NG) scan images. Conclusions: Coexistent thyroid diseases are responsible for mismatch between MIBI and US images resulting in equivocal HP localization. In these cases, FNA-PTH resulted in the most accurate tool to identify HP. However, although safe, it should be advised only to patients with uncertain HP localization.
Introduction
Primary hyperparathyroidism (pHPT) is an endocrine disease mainly caused by single or multiple hyperfunctioning parathyroid (HP) lesions (adenomas, hyperplasia, or rarely carcinomas) (1, 2). The identification of HP is an important step to plan surgery, which represents the definitive therapeutic approach of pHPT (3) . Although bilateral neck exploration (BNE) performed by an experienced surgeon may allow the intraoperative identification of HP (4) , in some cases, such as in the presence of concomitant thyroid nodular disease, this approach may fail. For this reason, preoperative localization studies have been regarded as necessary but their use is still controversial (5) . Some authors suggest that these studies may reduce surgical time, technical failures, complication rates (6), improving pHPT operation by minimally invasive parathyroidectomy (MIP) (7) , and radioguided (8, 9) surgery. Several imaging techniques such as neck ultrasound (US) (10, 11) , computerized tomography (CT) (12) , and dual-phase 99m technetium sestaMIBI (MIBI) scan associated with single-photon emission CT (SPECT)-CT are currently available (13) , although neck US and MIBI scan are generally used as first tools in the diagnostic approach of pHPT (14) .
MIBI is a lipophilic monovalent cation showing increased uptake in epithelial cells rich in mitochondria such as HP cells (15, 16) . MIBI scan is able to localize HP in pHPT patients with high sensitivity (71-93%) and specificity (90%) and, for this reason, it has been used as the technique of choice to guide MIP (17) . However, small dimension of HP, oxyphil cell content, and various degree of apoptosis or necrosis may reduce MIBI uptake causing false-negative results (18, 19) . On the other hand, MIBI retention is not parathyroid specific and is also observed in hypermetabolic thyroid nodules (TNs) such as oncocytic tumors (20) and autonomous thyroid adenomas (TA) (20, 21) . Neck US is the least invasive and cheapest method (11, 22) to accurately localize HP, but its efficacy is related to the operator experience and may be reduced in the presence of concomitant nodular goiter (NG) (23, 24) . No studies on the potential interference of autoimmune thyroid disease (AITD), such as Hashimoto's thyroiditis (HT) and Graves' disease (GD) in HP localization by MIBI scan and neck US, have been so far performed. Finally, other potential conditions leading to uncertain HP localization by these techniques are represented by ectopic parathyroid location, multiglandular HP hyperplasia, and exceptionally lymphoadenopathies (20, 24, 25) .
The association between TNs with pHPT occurs frequently in iodine-deficient areas (Italy or Central Europe) where the incidence of NG varies from 20 to 60%, and this has been reported to reduce the diagnostic performance of MIBI scan to w60-70%. In such a condition, the combined use of MIBI scan and neck US may also improve the diagnostic efficacy, but a 15-20% of inaccurate localization (20, 26, 27) still remains. In these last years, the assay of intact parathyroid hormone in washout fluid from fine-needle aspirate (FNA-PTH) has been proposed as a further diagnostic tool to improve the detection of HP in patients with NG (28, 29, 30) . However, this procedure is still a matter of controversy, mainly for the concern of subsequent technical difficulties in HP surgery (31) and potential mistakes in histological interpretation (32) .
With these concepts in mind, this study was aimed to reevaluate the potential interference of the most frequent thyroid diseases (NG and AITD) on MIBI scan and neck US diagnostic accuracy and redefine the diagnostic role and value of FNA-PTH in HP localization.
Materials and methods

Patients
We conducted a retrospective cohort study based on hospital records of 43 consecutive patients (ten males and 33 females, aged 37-80 years, and mean 59 years) with diagnosis of pHPT and concomitant NG (nZ32) or AITD (nZ9 HT and nZ2 GD) who were referred to the out clinic service of our Endocrinology Unit during a 6-year period (2003) (2004) (2005) (2006) (2007) (2008) . The diagnosis of pHPT was based on elevated serum PTH along with elevated or high normal range serum calcium (see Tables 1 and 2 ). The diagnosis of AITD was made in the presence of positive serum antithyroid autoantibodies (ATA), typical thyroid US hypoechoic pattern, and/or primary hypo/ hyperthyroidism. The diagnosis of NG was made by neck US in the presence of increased thyroid volume and/or in the presence of single or multiple TNs. All patients were also submitted to an accurate physical examination, MIBI scan, FNA-PTH measurement, and FNA cytology of their neck masses (a total of 63 neck lesions), performed as detailed later. The results of all diagnostic procedures were retrospectively reviewed. Written informed consent was obtained from each patient after full explanation of the purpose and nature Table 1 Clinical, biochemical, and pathological data in patients of group I: MIBI scan and neck US images fully concordant with HP localization.
Patient
Age Sex Serum PTH (pg/ml) of all procedures used. The Institutional Review Board of University Hospital of Cagliari reviewed and approved the protocol of this study. The choice of the surgical approach of pHPT was based on the results of all the diagnostic procedures employed to localize HP and on the basis of associated significant thyroid diseases, which may need surgical treatment. As detailed in the Results section, when patients obtained a satisfactory localization of their HP, a MIP was performed; in those with more than one suspicious HP or concomitant significant thyroid diseases, a BNE was preferred. Furthermore, in all cases, confirmation of radical pHPT treatment was reached either by the demonstration of intraoperative significant reduction of serum PTH and/or by persistent normalization of serum calcium levels.
Hormonal assays
Serum-free thyroxine (FT 4 ), free tri-iodothyronine (FT 3 ), and TSH were assayed by automatic ultrasensitive chemiluminescent assay (Ortho Clinical Diagnostic SpA, Milan, Italy). Anti-thyroperoxidase (TPOAb), anti-thyroglobulin (TgAb) autoantibodies, and PTH (in serum and in FNAB fluid) were measured by chemiluminescent assay: Immulite 2000 (Diagnostic Products Corporation, Los Angeles, CA, USA; distributor Medical Systems Corporation, Genoa, Italy) and anti-TSH receptor autoantibodies (TRAbs) by radioreceptor assay (TRAKhuman, BRAHMS, Hennigsdorf, Germany; distributor DASIT SpA, Milan, Italy). By these procedures, normal range values were as follows: FT 4 7.7-21.9 pg/ml, FT 3 2.77-5.27 pg/ml, TSH 0.2-3.0 mU/ml, TPOAb !35 IU/ml, TgAb !40 IU/ml, TRAb !1.0 U/ml, and serum PTH 1-87 pg/ml. For FNA-PTH, see the paragraph related to the cutoff values. Patients with increased ATA titers were considered ATA positive.
US with color flow doppler sonography
US and color flow doppler sonography (CFDS) of the neck were performed by one of the authors (F Boi) using a Sonoline G60S (Siemens, Medical Solutions, Issaquah, WA, USA) color Doppler system with a 8-13 mHz linear electronic transducer. The examiner was unaware of any prior imaging results using other techniques. The examination (conventional gray-scale US, followed by CFDS) included the central neck from the subclavian vein to the submandibular glands. The images were obtained with hyperextended position and lateral rotation of the neck to better visualize the common parathyroid ectopic sites (paraesophageal, paravertebral regions, within the thyroid gland, etc.). Enlarged parathyroid glands typically appear as an oval or triangular mass with sharp borders, homogenous hypoechoic texture with hypervascularization at CFDS. Usually, HP were found lying posterior and adjacent to the upper one-third of the thyroid lobes or adjacent to the lower pole. All neck masses were localized and their diameters were measured by US. The position of HP with respect to the thyroid gland was defined as follows: near to or inside the thyroid when HP were strictly adjacent or embedded in the thyroid, and distant when HP resulted clearly separated from thyroid lobes. US and CFDS standard criteria (20) were also employed to evaluate and select concomitant TNs to be submitted to FNA.
Parathyroid 99m Tc-MIBI scintigraphy
The patients received 400 MBq 99m Tc-MIBI (Cardiolite, Bristol-Meyers-Squibb, Brussels, Belgium) by i.v. injection. Anterior planar images of the neck and chest were obtained immediately after the injection (thyroid phase) and at 30 and 60 min later (parathyroid phase), each for 10 min, using a dual-head gamma camera (Varicam, General Electric Medical System, Milwaukee, WI, USA) equipped with high-resolution low-energy parallel-hole collimators. SPECT images of the same area were obtained after study of parathyroid phase with 120 frames at 25 s/frame and 38 angles over a 3608 arc. The images were acquired into a 128!128 matrix and reconstructed using Hanning filter. Thyroid scan was performed the following day with the same gamma camera. Anterior planar images were acquired 20 min after an i.v. injection of 4 mCi (152 MBq) of 99m Tc-pertechnetate. Visual analysis of the thyroid and MIBI scan were interpreted by experienced nuclear medicine physicians (M Piga and A Serra) who were unaware of US results. Patients were studied with standard MIBI scan integrated with SPECT/CT study to better evaluate the correspondence with neck US images. The MIBI scan was considered positive in locating abnormal parathyroid when one or more areas of increased and persistent MIBI uptake were detected in early and/or late acquisition and mismatched on 99m TcO4 uptake revealed by previous thyroid scan.
FNA cytology and FNA-PTH
Written informed consent was obtained before US-guided FNA, which was performed using 22-25 gauge needles attached to a 10 ml syringe. One or no more than two passes were performed on each neck lesion. FNA cytology and histology were performed by an experienced pathologist (M L Lai), who was unaware of neck US and MIBI images. Cytological diagnosis of TNs and HP was expressed according to standard criteria (20, 33) . For the purpose of this study, FNA cytology was considered 'positive' when suggestive of HP and 'negative' in the absence of HP features or inadequate sample. After smear preparation, the needle was washed out with 500 ml PTH-free serum dilution buffer and the solution processed for PTH measurement. Histological diagnosis on surgical specimens of HP and TNs was made using standard criteria and appropriate pathological techniques (20, 33, 34) .
Cutoff values for FNA-PTH
To correctly interpret the results of hormonal assays in FNA, we had to establish a cutoff above which FNA-PTH concentrations in washout fluid could be considered expression of local hormonal production, rather than the result of peripheral blood contamination. For this purpose, we retrospectively compared all hormonal FNA results from HP and not-HP of this series. On the basis of this analysis, all FNA-PTHs more than three times (103 pg/ml) the maximal concentration found in not-HP lesions (34.3 pg/ml) were considered positive and diagnostic for HP.
Statistical analysis
The sensitivity and specificity of the different tools to correctly detect HP were evaluated using Galen & Gambino formula (35) . The potential association between AITD and NG with the presence/absence of MIBI uptake was evaluated using nonparametric test (c 2 and exact Fisher's test, with 0.05 as the significance level) by Graphpad Prizmw (Graphpad Software Co., San Diego, CA, USA).
Results
Performance of the diagnostic tools in HP localization
Morphological (US) and functional (MIBI scan) images allowed the precise localization of HP in 16 patients (indicated as group I), which were confirmed by histology. In the remaining 27 patients (included in group II), US and MIBI images were discordant and identified 47 neck lesions displaying some features of HP, but, due to the presence of several degrees of mismatch, not allowing unequivocal identification of pathological parathyroids.
The complete results obtained in group I patients are detailed in Table 1 . All patients of this group showed a small goiter or a single small TN (!1 cm) both detected by neck US.
In this group, US and MIBI images were fully concordant, allowing, in each patient, the precise identification of a single well-distinct lesion, strongly suggestive of HP. Moreover, all these MIBI-positive lesions showed high FNA-PTH concentrations (517-O2500 pg/ml), resulting in all cases pathological HP (15 parathyroid adenomas (PAs) and one parathyroid hyperplasia (PH)) at histology. FNA cytology was positive only in 9/16 (56.2%) of cases.
In group II patients, palpation and neck US displayed a larger goiter and/or multiple TNs. In this group, we were able to identify at least four different patterns of mismatch (described as subgroups A, B, C and D) of these procedures. All the results obtained in this group are detailed in Table 2 .
In all patients of group II-A (nZ10), MIBI uptake was always absent (Fig. 1a) and HP was suspected by neck US (Fig. 1b) in seven of ten. These seven lesions displayed very high FNA-PTH concentrations (366-O2500 pg/ml) and were confirmed HP at histology (six PA and one parathyroid carcinoma (PC)). Each of the remaining three patients displayed at US two neck lesions with a echographic pattern insufficient for a clear identification of parathyroid tissue. High FNA-PTH values (O2500 pg/ml) were found only in one lesion of each patient, which was confirmed HP (two PA and one PH) at histology. The other three lesions with low FNA-PTH concentrations (4.4-16 pg/ml) resulted in thyroid origin (one TA and one papillary thyroid carcinoma (PTC), and one hyperplasic TN (HTN)) at histology.
Each patient of group II-B (nZ4) exhibited one or more MIBI-positive areas projected on neck nodule 
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www.eje-online.org (Fig. 1c) without US features of HP, while an other neck lesion suggestive of HP at US (Fig. 1d) did not show any MIBI uptake. All four MIBI-negative neck lesions identified by US had high FNA-PTH values (741-O 2500 pg/ml) and all resulted HP at histology (three PA and one PH). All five MIBI-positive masses (a single lesion from three patients and a double mass from one case) showing low levels of FNA-PTH (!3-34.3 pg/ml) resulted in thyroid lesion (two HTNs, one hyperfunctioning TA, and one oncocytic variant of follicular carcinoma (FC)) with exception of patient #2 who had a local recurrence of neck lymphoma at histology. Each patient of group II-C (nZ4) had two distinct and separate MIBI-positive areas; in three patients, MIBI focuses were projected in the lower third of the neck, and in the remaining case, one focus was projected in the jugular area and the other in the hilum of the left lung. Of these seven neck MIBI-positive lesions, 4/7 results were suggestive of HP at US examination and were confirmed HP at histology. High FNA-PTH (366-O2500 pg/ml) was found in a total of 5/7 neck lesions, all HP at histology (patient #1 had double PA and three patients had a single PA). In two patients (#2 and #3), the other neck MIBI-positive focus showed low FNA-PTH (5.9-6 pg/ml) and in both cases resulted PTC at histology: one of these cases (patient #2), a rare association between MIBI-positive PA and PTC (Fig. 1e  and f) , has been previously reported (26) . In patient #4, the other MIBI-positive area, located in the lung, resulted in a recurrence of lung neoplasia.
In each patient of group II-D (nZ9), a single MIBI focus was projected in a neck area where two similar, hypoechoic adjacent masses (Fig. 1g and h ) were found at US. Of these 18 neck lesions, five results were suggestive of HP at US examination and were confirmed HP at histology. High FNA-PTH (2332-O2500 pg/ml) was found in a total of 9/18 lesions, all resulting HP at histology (nine PA). All the other nine lesions with low FNA-PTH (!3-33.6 pg/ml) resulted thyroid neoplasias ((four HTNs, two TAs (one classic and one oncocytic variant), and three PTC (two classic and one oncocytic variant)) at histology.
The accuracy of all diagnostic procedures (MIBI scan, neck US, FNA-PTH, and FNA cytology) was calculated according to the Galen & Gambino formula (35) . For this purpose, MIBI uptake was considered true positive when the mass was confirmed HP at histology, false positive when the lesion resulted not-HP (i.e. TN), true negative when the mass was confirmed not-HP, and false negative when HP resulted MIBI negative. For neck US, it was considered true positive when the mass suggestive of HP was confirmed at histology, false positive when the suspected lesion resulted in notparathyroid origin, true negative when US correctly identified the other neck masses, and false negative when US failed to identify HP. For FNA-PTH, true positive was considered a value O103 pg/ml found in histologically proven HP and true negative was considered all values !103 pg/ml found in lesions of not-parathyroid origin. FNA cytology was considered true positive when the neck mass corresponded to HP at histology and false negative when cytology results were inadequate or not indicative of HP in histologically proven parathyroid lesions. In group I patients (Table 1) , almost all techniques (MIBI scan, neck US, and FNA-PTH) allowed the correct identification of all HP, reaching 100% sensitivity, while FNA cytology resulted in only 56.2% sensitivity.
As shown in Fig. 2 and Table 3 , in the whole series of group II patients, all neck masses with positive FNA-PTH values (366-O2500 pg/ml) resulted HP at histology, while low FNA-PTH concentrations (!3-33.6 pg/ml) were only found in not-HP lesions. and inadequate in 6/28 (21.4%). In summary, as displayed in Fig. 3 , in group II patients, FNA-PTH resulted in the best procedure able to identify all HP reaching 100% sensitivity and specificity; neck US reached 71.4% sensitivity and 78.9% specificity; MIBI scan 35.7% sensitivity and 42.1% specificity; and FNA cytology 53.6% sensitivity and 100% specificity. Thanks to the above procedures, in patients with a fully satisfactory localization of HP (all 16 patients of group I) and in several cases with significant thyroid or other diseases (the first eight cases of group II-A, the patient with associated recurrence of neck lymphoma (group II-B), the case with mediastinum recurrence of lung neoplasia (group II-C) and four patients (#3, #5, #7, and #9) with small thyroid tumors of group II-D) who displayed an unequivocal identification of HP by FNA-PTH assay (a total of 14 of 27, 52% of patients of group II), an adequate MIP (unilateral neck exploration) was performed. The remaining patients (13 of 27, 48% of patients of group II) who exhibited more than one suspicious HP or a large NG/thyroid tumors, which required an extensive surgical treatment, were submitted to a BNE.
Finally, in the postoperative 6-month follow-up, almost all (39/40, 97.5%) patients with histological diagnosis of PA reached radical pHPT treatment, while only one case displayed recurrence of pHPT. On the other hand, one of the three patients with PH and the patient with PC showed persistence of pHPT.
Thyroid diseases and HP localization: effect of thyroid autoimmunity on MIBI scan
When the results obtained with MIBI scan in group II patients were analyzed according to the nature of associated thyroid disorders, a significant increase of false-negative MIBI scans were found in the ten patients with AITD (8/10, 80%) when compared with patients with NG (6/17, 35.3%; P!0.05). In contrast, no falsepositive MIBI scans were found in patients with associated AITD. Almost all (10/12, 83.3%) cases of false-positive MIBI uptake were caused by TNs. In particular, between the five thyroid carcinomas, two were an oncocytic variant of FC and PTC and the remaining were three cases of classic variant of PTC; between the five benign lesions, there were three TA (one oncocytic variant, one hyperfunctioning, and one classic variant) and the remaining were two HTNs. The other two false-positive MIBI scans were represented by a neck lymphoma and a recurrence of lung neoplasia.
On the whole, as displayed in Tables 1 and 2 , FNA cytology allowed the correct identification of seven concomitant malignant thyroid tumors (nZ6 PTC, nZ1 FC) and 11 benign thyroid lesions (nZ3 TA and nZ8 HTNs) associated with HP, which needed to be removed in the same surgical time.
Discussion
Neck US and MIBI scan represent the first diagnostic tools to correctly plan surgery of HP (10) in the absence of concomitant cervical masses (14) . False-negative neck US results may be rarely found in cases with small and ectopic HP, intrathyroidal HP, and underscent HP situated along the common carotid artery or recurrent laryngeal nerve, while false-negative MIBI scans have been observed in the presence of small size, low oxyphil cell content, and morphological changes (cystic degeneration, apoptosis, or necrosis) of HP (18, 19) . On the other hand, difficulty in neck US and MIBI scan interpretation has been described in the presence of TNs (20, 26, 36) with high rate of false-positive images (15-20%) for both techniques (24, 37) ; blood vessels, esophagus, longus colli muscle, and enlarged lymph nodes (37) may represent other rare sources of falsepositive results. In contrast with nodular thyroid diseases, no studies on the potential interference of concomitant AITD in the diagnostic approach of pHPT by MIBI scan and neck US have been so far performed. Despite the usefulness of FNA-PTH in cases with inconclusive neck US and MIBI scan results, some authors reported (31) that FNA technique may be responsible for HP damage leading to fibrosis, with potential incomplete removal of HP, increased risk of laryngeal nerve injury, and the induction of false worrisome histology, which can be mistaken for carcinoma (32) . These authors concluded that the routine use of this technique is unnecessary and should be avoided. This topic is still a matter of controversy, as Abraham et al. (38) rebutted that the above complications were caused by the use of large-bore needles and excessive number of FNA passes performed by operators of unknown skill levels.
With the above issue in mind, to reevaluate the real impact of the main thyroid diseases and to redefine the diagnostic role of FNA-PTH in HP diagnostic evaluation, all data from pHPT patients with coexistent NG (33, 34) . The different diagnostic accuracy between these FNA techniques is explained by the minimal amount of material needed to assay PTH-FNA, which was not sufficient for cytology. The analysis of false-negative MIBI results of group II patients showed only in 2/14 cases the presence of known interfering factors of MIBI uptake, such as small size and cystic degeneration of two PA (patients #3 and #4 of group II-A), while in the remaining 8/12 cases (66.7%) a concomitant AITD (seven HT and one GD) was detected. It may be hypothesized that the inflammatory process related to AITD might be responsible for MIBI-negative scan by interferences on the mechanism of uptake, retention, and/or washout time of MIBI by parathyroid cells. To our knowledge, this is the first description of this association and further investigations are needed to better characterize the real prevalence of AITD in pHPT patients and clarify the potential interfering mechanism on MIBI function.
This study also confirms that MIBI false-positive scans (all detected in group II) were mainly caused by increased MIBI uptake of concomitant TNs. As previously reported (20) , MIBI retention was observed in hypermetabolic oncocytic tumors (one oncocytic variant of TA and two oncocytic variants of PTC and FC) and TA (one hyperfunctioning adenoma and one classic variant), while the remaining five MIBI-positive scans were represented by three classic variants of PTC and two HTNs. Moreover, two other sources of MIBI false-positive uptake were represented by a recurrence of neck lymphoma and a mediastinum recurrence of lung neoplasia.
In our study, FNA was well tolerated, no complications and fibrosis were observed in any of the aspirated glands; no difficulties in operating setting and in distinguishing benign from malignant HP were reported when comparing this series with patients not submitted to this procedure (not reported in this paper). This good performance was obtained by adopting some technical precautions, as the use of small thin-bore needles (22-25 gauge) and a limited number (not more than one or two) of not-traumatic passes on all neck masses. Accordingly, with Abraham et al. (38) , FNA resulted in a safe technique when the above-described procedures were applied. However, it should be noted that in the presence of suspicious multiple parathyroid gland disease (or in patients with concomitant significant thyroid diseases), as well as in the presence of a truepositive result of PTH-FNA, other diagnostic imaging techniques (e.g. CT or magnetic resonance) may be proposed before a BNE in order to correctly find all HP and avoid recurrence or persistence of pHPT. We conclude that US-guided FNA-PTH should be used appropriately only in selected cases (i.e. when US and MIBI scan give conflicting results such as MIBI-negative cases, atypical location, multiple positive MIBI areas, as may happen in AITD/NG patients) and not applied routinely in pHPT. This technique helps the surgeon to perform a quicker operation with a higher degree of success and as an added benefit enables the identification of incidental thyroid tumors that coexist with pHPT (40) that can be effectively addressed during the same surgery.
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